These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15056469)

  • 1. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase.
    Klivenyi P; Calingasan NY; Starkov A; Stavrovskaya IG; Kristal BS; Yang L; Wieringa B; Beal MF
    Neurobiol Dis; 2004 Apr; 15(3):610-7. PubMed ID: 15056469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study.
    in 't Zandt HJ; Renema WK; Streijger F; Jost C; Klomp DW; Oerlemans F; Van der Zee CE; Wieringa B; Heerschap A
    J Neurochem; 2004 Sep; 90(6):1321-30. PubMed ID: 15341516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine and cyclocreatine attenuate MPTP neurotoxicity.
    Matthews RT; Ferrante RJ; Klivenyi P; Yang L; Klein AM; Mueller G; Kaddurah-Daouk R; Beal MF
    Exp Neurol; 1999 May; 157(1):142-9. PubMed ID: 10222117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered brain phosphocreatine and ATP regulation when mitochondrial creatine kinase is absent.
    Kekelidze T; Khait I; Togliatti A; Benzecry JM; Wieringa B; Holtzman D
    J Neurosci Res; 2001 Dec; 66(5):866-72. PubMed ID: 11746413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete brain-type creatine kinase deficiency in mice blocks seizure activity and affects intracellular calcium kinetics.
    Streijger F; Scheenen WJ; van Luijtelaar G; Oerlemans F; Wieringa B; Van der Zee CE
    Epilepsia; 2010 Jan; 51(1):79-88. PubMed ID: 19624717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of creatine.
    Beal MF
    Amino Acids; 2011 May; 40(5):1305-13. PubMed ID: 21448659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of (phospho)creatine in developing and adult skeletal muscle of mice without mitochondrial and cytosolic muscle creatine kinase isoforms.
    in 't Zandt HJ; de Groof AJ; Renema WK; Oerlemans FT; Klomp DW; Wieringa B; Heerschap A
    J Physiol; 2003 May; 548(Pt 3):847-58. PubMed ID: 12640020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
    Abdel-Wahab MH
    J Biochem Mol Toxicol; 2005; 19(1):32-41. PubMed ID: 15736157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    Cleren C; Starkov AA; Calingasan NY; Lorenzo BJ; Chen J; Beal MF
    Neurobiol Dis; 2005 Dec; 20(3):701-8. PubMed ID: 16126396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H; Kurosaki R; Oki C; Araki T
    Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
    Oida Y; Kitaichi K; Nakayama H; Ito Y; Fujimoto Y; Shimazawa M; Nagai H; Hara H
    Brain Res; 2006 Apr; 1082(1):196-204. PubMed ID: 16515773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel cyclooxygenase-2 inhibitor GW637185X protects against l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Aguirre JA; Leo G; Cueto R; Andbjer B; Naylor A; Medhurst AD; Agnati LF; Fuxe K
    Neuroreport; 2008 Apr; 19(6):657-60. PubMed ID: 18382281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol.
    D'Astous M; Morissette M; Callier S; Di Paolo T
    J Neurosci Res; 2005 Apr; 80(1):138-44. PubMed ID: 15723346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.
    Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR
    Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
    Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.